Condensed Consolidated Statements Of Cash Flows (USD $) In Thousands, unless otherwise specified	3 Months Ended
	Mar. 31, 2013	Mar. 31, 2012
OPERATING ACTIVITIES:
Consolidated net income (loss)	$ 26,603	$ (74,525)
Adjustments to reconcile consolidated net income (loss) to Net cash used in operating activities
Depreciation and amortization	66,819	66,957
Stock-based compensation	15,331	14,518
Amortization of debt issuance costs and premium / discount	9,776	7,868
Provision for bad debts	744	0
Selling, general and administrative expenses paid in shares of common stock	69	118
Deferred income taxes	8,644	(24,461)
Net loss on disposal of property, plant and equipment	213	26
Change in fair value of acquisition-related contingent consideration	40	(127)
Net loss on extinguishment of debt	11,312	5,426
Asset impairment charges	1,100	40,000
Changes in assets and liabilities which provided (used) cash:
Accounts receivable	(21,989)	77,138
Inventories	(27,153)	(26,297)
Prepaid and other assets	1,476	703
Accounts payable	(136,323)	(4,118)
Accrued expenses	(94,160)	(3,301)
Other liabilities	86,922	(19,056)
Income taxes payable/receivable	(8,171)	(73,931)
Net cash used in operating activities	(58,747)	(13,062)
INVESTING ACTIVITIES:
Purchases of property, plant and equipment	(23,956)	(29,112)
Proceeds from sale of property, plant and equipment	311	191
Acquisitions, net of cash acquired	(3,645)	0
Patent acquisition costs and license fees	(10,000)	(5,000)
Net cash used in investing activities	(37,290)	(33,921)
FINANCING ACTIVITIES:
Capital lease obligations repayments	(89)	(127)
Direct financing arrangement repayments	(857)	0
Proceeds from other indebtedness	223	0
Principal payments on Term Loans	(100,000)	(219,063)
Principal payments on other indebtedness	0	(439)
Deferred financing fees	(7,251)	0
Payment for contingent consideration	(5,000)	0
Tax benefits of stock awards	1,998	3,521
Exercise of Endo Health Solutions Inc. stock options	12,826	9,543
Purchase of common stock	0	(33,000)
Issuance of common stock from treasury	1,557	1,412
Cash distributions to noncontrolling interests	(12,832)	(13,120)
Buy-out of noncontrolling interests, net	(1,525)	(849)
Net cash used in financing activities	(110,950)	(252,122)
Effect of foreign exchange rate	(412)	(212)
NET DECREASE IN CASH AND CASH EQUIVALENTS	(207,399)	(299,317)
CASH AND CASH EQUIVALENTS, BEGINNING OF PERIOD	547,916	547,620
CASH AND CASH EQUIVALENTS, END OF PERIOD	340,517	248,303
SUPPLEMENTAL INFORMATION:
Cash paid for interest	40,714	52,938
Cash paid for income taxes	993	54,405
SCHEDULE OF NON-CASH INVESTING AND FINANCING ACTIVITIES
Accrual for purchases of property, plant and equipment	$ 4,083	$ 3,961